New EU Project Could Make Comparative Rare Diseases Trials More Feasible For Companies

 
• By Francesca Bruce

A new Innovative Health Initiative project will see the German health technology appraisal (HTA) body, IQWiG, work towards ensuring evidence generated in clinical studies meets the needs of HTA bodies and regulators.

A new initiative could help companies better conduct comparative clinical trials for ultra-rare disease treatments. (Shutterstock)

More from Europe

More from Rare Diseases